Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma | |
Jin, Jie; Okamoto, Rumiko; Yoon, Sung-Soo; Shih, Lee-Yung; Zhu, Jun; Liu, Ting; Hong, Xiaonan; Pei, Lixia; Rooney, Brendan; van de Velde, Helgi | |
刊名 | ONCOTARGETS AND THERAPY |
2018 | |
卷号 | 11 |
关键词 | mantle-cell lymphoma bortezomib VR-CAP R-CHOP |
ISSN号 | 1178-6930 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3605667 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Jin, Jie,Okamoto, Rumiko,Yoon, Sung-Soo,et al. Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma[J]. ONCOTARGETS AND THERAPY,2018,11. |
APA | Jin, Jie.,Okamoto, Rumiko.,Yoon, Sung-Soo.,Shih, Lee-Yung.,Zhu, Jun.,...&Huang, Huiqiang.(2018).Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma.ONCOTARGETS AND THERAPY,11. |
MLA | Jin, Jie,et al."Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma".ONCOTARGETS AND THERAPY 11(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论